RCM Rollups Create Opportunity for Commure

Diving deeper into

Commure

Company Report
The RCM space has attracted significant private equity investment, with firms consolidating point solutions into broader platforms.
Analyzed 7 sources

Private equity money has been reshaping RCM into a bundle business, not a single tool business. The basic play is to buy separate products for claims submission, eligibility checks, payment posting, denial management, and patient billing, then sell them together as one platform to hospitals that want fewer vendors and fewer handoffs. That matches Commure’s own direction, where RCM is one module inside a broader hospital software stack that also includes documentation, patient engagement, and operations tools.

  • Waystar is a clean example of the roll up model. It was created by merging Navicure and ZirMed, then added eSolutions, turning separate clearinghouse, claims, and Medicare workflow products into one cloud RCM platform backed by Bain, EQT, and CPP Investments.
  • At the large end of the market, traditional RCM leaders have also moved into financial sponsor or platform ownership. R1 agreed to be taken private by TowerBrook and CD&R for $8.9B in 2024, while Change Healthcare was acquired by UnitedHealth Group in October 2022 and folded into Optum.
  • This matters because hospitals increasingly want one vendor that can touch the full path from clinical note to final payment. Commure already processes over $5B in annual claims, sells modules in enterprise contracts that often start at $1M per year, and has used acquisitions like PatientKeeper, Strongline, and Augmedix to widen that cross sell surface.

The next phase of RCM will look more like hospital operating software than back office billing software. The winners will be platforms that connect front end intake, documentation, coding, claims, and patient payments in one workflow, which gives Commure room to turn RCM from a useful module into a wedge for broader enterprise standardization.